(+)-catechin multiple interactions ISO RGD:1351112 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of KCNT2 mRNA CTD PMID:24763279 17alpha-ethynylestradiol increases expression ISO RGD:735074 6480464 Ethinyl Estradiol results in increased expression of KCNT2 mRNA CTD PMID:17557909 3-chloropropane-1,2-diol increases expression ISO RGD:735074 6480464 alpha-Chlorohydrin results in increased expression of KCNT2 protein CTD PMID:26597043 6-propyl-2-thiouracil increases expression ISO RGD:735074 6480464 Propylthiouracil results in increased expression of KCNT2 mRNA CTD PMID:24780913 aflatoxin B1 decreases methylation ISO RGD:1351112 6480464 Aflatoxin B1 results in decreased methylation of KCNT2 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1351112 6480464 Aflatoxin B1 results in decreased expression of KCNT2 mRNA CTD PMID:27153756 antirheumatic drug decreases expression ISO RGD:1351112 6480464 Antirheumatic Agents results in decreased expression of KCNT2 mRNA CTD PMID:24449571 arsenite(3-) increases methylation ISO RGD:1351112 6480464 arsenite results in increased methylation of KCNT2 promoter CTD PMID:23974009 bazedoxifene increases expression ISO RGD:1351112 6480464 bazedoxifene results in increased expression of KCNT2 mRNA CTD PMID:19914376 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of KCNT2 mRNA CTD PMID:19770486 beta-naphthoflavone multiple interactions ISO RGD:735074 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of KCNT2 mRNA CTD PMID:18164116 butanal decreases expression ISO RGD:1351112 6480464 butyraldehyde results in decreased expression of KCNT2 mRNA CTD PMID:26079696 calcitriol increases expression ISO RGD:1351112 6480464 Calcitriol results in increased expression of KCNT2 mRNA CTD PMID:16002434 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon analog results in increased expression of KCNT2 mRNA; more ... CTD PMID:25620056 catechin multiple interactions ISO RGD:1351112 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of KCNT2 mRNA CTD PMID:24763279 copper atom multiple interactions ISO RGD:1351112 6480464 [NSC 689534 binds to Copper] which results in decreased expression of KCNT2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1351112 6480464 [NSC 689534 binds to Copper] which results in decreased expression of KCNT2 mRNA CTD PMID:20971185 copper(2+) multiple interactions ISO RGD:1351112 6480464 [NSC 689534 binds to Copper] which results in decreased expression of KCNT2 mRNA CTD PMID:20971185 cyclosporin A increases expression ISO RGD:1351112 6480464 Cyclosporine results in increased expression of KCNT2 mRNA CTD PMID:20106945 dioxygen increases expression ISO RGD:1351112 6480464 Oxygen deficiency results in increased expression of KCNT2 mRNA CTD PMID:26100633 dorsomorphin multiple interactions ISO RGD:1351112 6480464 [NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNT2 mRNA CTD PMID:27188386 endosulfan increases expression ISO RGD:735074 6480464 Endosulfan results in increased expression of KCNT2 mRNA CTD PMID:29391264 entinostat decreases expression ISO RGD:1351112 6480464 entinostat results in decreased expression of KCNT2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1351112 6480464 [NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNT2 mRNA CTD PMID:27188386 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of KCNT2 mRNA CTD PMID:20003209 N-methyl-4-phenylpyridinium increases expression ISO RGD:1351112 6480464 1-Methyl-4-phenylpyridinium results in increased expression of KCNT2 mRNA CTD PMID:24810058 N-nitrosodiethylamine multiple interactions ISO RGD:735074 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of KCNT2 mRNA CTD PMID:18164116 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of KCNT2 mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of KCNT2 mRNA CTD PMID:24535843 paracetamol decreases expression ISO RGD:1351112 6480464 Acetaminophen results in decreased expression of KCNT2 mRNA CTD PMID:21420995 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1351112 6480464 perfluorooctane sulfonic acid results in decreased expression of KCNT2 mRNA CTD PMID:27153767 phenethyl caffeate decreases expression ISO RGD:735074 6480464 caffeic acid phenethyl ester results in decreased expression of KCNT2 mRNA CTD PMID:26100633 phenobarbital multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of KCNT2 mRNA CTD PMID:24535843 progesterone increases expression ISO RGD:1351112 6480464 Progesterone results in increased expression of KCNT2 mRNA CTD PMID:21795739 SB 431542 multiple interactions ISO RGD:1351112 6480464 [NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNT2 mRNA CTD PMID:27188386 sodium arsenite increases expression ISO RGD:1351112 6480464 sodium arsenite results in increased expression of KCNT2 mRNA CTD PMID:22714537 trichostatin A increases expression ISO RGD:1351112 6480464 trichostatin A results in increased expression of KCNT2 mRNA CTD PMID:24935251 tunicamycin increases expression ISO RGD:1351112 6480464 Tunicamycin results in increased expression of KCNT2 mRNA CTD PMID:22378314 valproic acid affects expression ISO RGD:1351112 6480464 Valproic Acid affects the expression of KCNT2 mRNA CTD PMID:25979313 valproic acid decreases methylation ISO RGD:1351112 6480464 Valproic Acid results in decreased methylation of KCNT2 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1351112 6480464 Valproic Acid results in increased expression of KCNT2 mRNA CTD PMID:24935251 PMID:26705709 valproic acid decreases expression ISO RGD:1351112 6480464 Valproic Acid results in decreased expression of KCNT2 mRNA CTD PMID:23179753 more ...
Biological Process potassium ion export across plasma membrane ISO UniProtKB:Q6UVM3 2290270 MGI GO_REF:0000096 MGI:MGI:4834177 potassium ion transport ISO EMBL:AY359443 2290270 MGI GO_REF:0000008 MGI:MGI:2154458 regulation of membrane potential IBA MGI:MGI:99923|PANTHER:PTN000002872|UniProtKB:Q12791 2290270 GO_Central PMID:21873635 Cellular Component integral component of membrane IBA MGI:MGI:99923|PANTHER:PTN000002872|RGD:621106|UniProtKB:Q12791 2290270 GO_Central PMID:21873635 plasma membrane ISO EMBL:AY359443 2290270 MGI GO_REF:0000008 MGI:MGI:2154458 plasma membrane IBA MGI:MGI:99923|PANTHER:PTN000002872|RGD:620715 2290270 GO_Central PMID:21873635 plasma membrane ISO UniProtKB:Q6UVM3 2290270 MGI GO_REF:0000096 MGI:MGI:4834177 Molecular Function chloride-activated potassium channel activity ISO UniProtKB:Q6UVM3 2290270 MGI GO_REF:0000096 MGI:MGI:4834177 intracellular sodium activated potassium channel activity IBA FB:FBgn0261698|PANTHER:PTN000798363 2290270 GO_Central PMID:21873635 outward rectifier potassium channel activity IBA PANTHER:PTN000002872|WB:WBGene00004831 2290270 GO_Central PMID:21873635 potassium channel activity ISO EMBL:AY359443 2290270 MGI GO_REF:0000008 MGI:MGI:2154458
Gene-Chemical Interaction Annotations
